EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access

Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial

Jun Hamano iD, Takahiro Higashibata iD, Takaomi Kessoku iD, Shinya Kajiura iD, Mami Hirakawa iD, Shunsuke Oyamada iD, Keisuke Ariyoshi, Takeshi Yamada iD, Yoshiyuki Yamamoto iD, Yasuyuki Takashima, Kosuke Doki iD, Masato Homma und 14 weitere

Journal of Clinical Oncology · 2024

DOI: 10.1200/jco.24.00381 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Clinical Oncology, 2024. Verfasst von Jun Hamano und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Palliative and Supportive Care, Institute of Medicine, University of Tsukuba, Tsukuba, Japan. Hauptthemen laut MEDLINE: Naltrexone, Opioid-Induced Constipation, Cancer Pain, Analgesics, Opioid. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Opioid-induced constipation is the most frequent and non–self-limiting adverse effect of opioid analgesia, reducing adherence and interfering with pain relief. This clinical trial aimed to clarify the preventive effect of naldemedine versus placebo for constipation in patients with cancer starting regularly dosed strong opioids therapy. METHODS This multicenter, double-blinded, randomized, placebo-controlled, confirmatory trial was conducted between July 2021 and May 2023 at four academic hospitals in Japan (Japan Registry of Clinical Trials identifier: jRCTs031200397). Patients with cancer starting a first-time regularly dosed strong opioid for cancer pain and age 20+ years were included. Eligible patients were randomly assigned to the naldemedine (Symproic 0.2 mg) or placebo group in a 1:1 ratio for 14 days with protocol treatment. The primary end point was the proportion of patients with a Bowel Function Index (BFI) of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NaltrexoneOpioid-Induced ConstipationCancer PainAnalgesics, OpioidNeoplasmsNarcotic AntagonistsHumansDouble-Blind MethodMaleFemaleMiddle AgedAgedQuality of LifeAdultJapanConstipation

Substanzen

naldemedineNaltrexoneAnalgesics, OpioidNarcotic Antagonists

Autor:innen und Institutionen

  • Department of Palliative and Supportive Care, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Department of Palliative and Supportive Care, University of Tsukuba Hospital, Tsukuba, Japan.
  • Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Department of Gastroenterology, International University Health and Welfare Graduate School of Medicine, Narita, Japan.
  • Department of Palliative Medicine and Gastroenterology, International University Health and Welfare Narita Hospital, Narita, Japan.
  • Department of Clinical Oncology, University of Toyama, Toyama, Japan.

ORCID-Profile: Jun Hamano, Takahiro Higashibata, Takaomi Kessoku, Shinya Kajiura, Mami Hirakawa, Shunsuke Oyamada, Takeshi Yamada, Yoshiyuki Yamamoto, Kosuke Doki, Bryan J Mathis, Tsumugi Jono, Kosuke Tanaka, Ryuji Hayashi, Naoki Izawa

Zitieren

APA

Hamano, J., Higashibata, T., Kessoku, T., Kajiura, S., Hirakawa, M., Oyamada, S., Ariyoshi, K., Yamada, T., Yamamoto, Y., Takashima, Y., Doki, K., Homma, M., Mathis, B. J., Jono, T., Ogata, T., Tanaka, K., Kasai, Y., Iwaki, M., Fuyuki, A., …, & Morita, T. (2024). Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.00381

Vancouver

Hamano J, Higashibata T, Kessoku T, Kajiura S, Hirakawa M, Oyamada S, et al. Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial. Journal of Clinical Oncology. 2024. doi:10.1200/jco.24.00381

BibTeX
@article{Hamano2024,
  author = {Hamano, Jun and Higashibata, Takahiro and Kessoku, Takaomi and Kajiura, Shinya and Hirakawa, Mami and Oyamada, Shunsuke and Ariyoshi, Keisuke and Yamada, Takeshi and Yamamoto, Yoshiyuki and Takashima, Yasuyuki and Doki, Kosuke and Homma, Masato and Mathis, Bryan J and Jono, Tsumugi and Ogata, Tomoki and Tanaka, Kosuke and Kasai, Yuki and Iwaki, Michihiro and Fuyuki, Akiko and Nakajima, Atsushi and Hayashi, Ryuji and Ando, Takayuki and Izawa, Naoki and Kobayashi, Yuko and Horie, Yoshiki and Morita, Tatsuya},
  title = {Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial},
  journal = {Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1200/jco.24.00381}
}
Kostenlos starten →